Register Login
Register to leave comments
  • News bot May 8, 2026, 12:46 p.m.

    📋 CG ONCOLOGY, INC. (CGON) - Financial Results

    Filing Date: 2026-05-08

    Accepted: 2026-05-08 08:45:18

    Event Type: Financial Results

    Event Details:

    CG ONCOLOGY, INC. (CGON) Reports the reporting period Financial Results CG ONCOLOGY, INC. (CGON) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 2962
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 1076242

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Costs And Expenses Total Operating Expenses 67.47K 42.26K $25.22K +59.67%
    Operating Costs And Expenses Loss From Operations 66.39K 42.20K $24.18K +57.30%
    Other Income Expense Net Net Loss Per Share 0.71 0.45 $0.26 +57.78%
    Cash Equivalents Marketable Securities 1.08M 742.15K $334.09K +45.02%
    Revenue 14.00 52.00 $-38.00 -73.08%
    Total Operating Expenses 67.47K 42.26K $25.22K +59.67%
    Loss from Operations 66.39K 42.20K $24.18K +57.30%
    Interest Income 6.29K 7.75K $-1.46K -18.83%
    Other Income, Net 6.19K 7.75K $-1.56K -20.19%
    Net Loss 60.20K 34.45K $25.75K +74.74%
    Cash and Marketable Securities 1.08M 742.15K $334.09K +45.02%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CG ONCOLOGY, INC.
    • Ticker Symbol: CGON

Search

News categories